The week in health tech, explained in plain English.Get the free newsletter →
October 27, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

ACA Subsidy Lapse Lifts Payer Margins, Strains Hospitals

The expiration of the Affordable Care Act's enhanced premium tax credits is reshaping the economics of coverage, with insurers and hospitals landing on opposite sides of the fallout, according to Becker's Hospital Review.

The enhanced credits lowered exchange premiums for millions of enrollees before lapsing at the end of the year. As premiums rise, healthier and lower-cost members are the first to drop coverage. That leaves several insurers with a smaller but relatively more profitable risk pool, lifting margins even as enrollment shrinks.

Hospitals face the opposite pressure. Newly uninsured patients keep seeking care, worsening payer mix and driving up uncompensated care costs for the nation's largest operators. The dynamic sets up a widening gap between payer profitability and provider financial strain, and it puts the spotlight on Congress over whether the subsidies get restored. For executives on both sides, the coverage cliff is now a balance-sheet issue, not just a policy debate.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.